Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Details Narrative)

v3.21.1
Stock-Based Compensation (Details Narrative) - USD ($)
12 Months Ended
Aug. 12, 2020
Aug. 01, 2020
Jul. 15, 2020
Jul. 14, 2020
Jul. 03, 2020
Aug. 04, 2019
Jul. 23, 2019
May 22, 2019
Aug. 04, 2018
Sep. 14, 2015
Jun. 20, 2007
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Jul. 02, 2020
Dec. 31, 2018
Sep. 14, 2017
Sep. 14, 2016
Stock options granted to purchase common stock, issued               33,333                    
Stock options granted to purchase common stock, outstanding                       1,475,000 1,475,000 1,308,333   1,291,667    
Stock option vested exercisable term               5 years                    
Stock options are exercisable price per share               $ 6.60                    
Number of fully vested option issued                         27,420          
Stock price per share               $ 5.6718       $ 3.65 $ 3.65          
Stock options fully vested amount, fair value               $ 189,060         $ 100,000          
Stock based compensation                         1,251,349 $ 748,655        
Total deferred compensation expense for outstanding value of unvested stock options                         894,000          
Intrinsic value of exercisable but unexercised in-the-money stock options                       $ 747,750 $ 747,750          
Fair market value, per share                         $ 3.17          
Outstanding stock options to acquire shares of common stock not vested                       150,000 150,000          
Board of Directors [Member]                                    
Number of warrants outstanding acquire common stock         166,666                          
Warrants term, description         September 14, 2020 to September 14, 2025                          
Closing stock price of warrants                             $ 5.40      
Collaboration Agreement [Member] | BioPharmaWorks [Member]                                    
Stock price per share                   $ 4.0242                
Stock options fully vested amount, fair value                   $ 670,715                
Number of warrants to purchase common stock                   166,666                
Number of warrants to purchase common stock per warrant                   83,333                
Warrant exercisable term                                 5 years 5 years
Warrants exercise price                                 $ 12.00 $ 6.00
General and Administrative Expense [Member]                                    
Stock based compensation                           $ 31,046        
Winson Sze Chun Ho [Member]                                    
Stock options granted to purchase common stock, issued                 33,333                  
Stock option vested exercisable term                 5 years                  
Stock options are exercisable price per share                 $ 1.68                  
Number of fully vested option issued           16,667     16,667                  
Fair value of stock options                 $ 104,920                  
Stock price per share                 $ 1.5738                  
Stock options fully vested amount, fair value                 $ 101,475                  
Dr. Yun Yen [Member]                                    
Stock options granted to purchase common stock, issued               8,333 33,333                  
Stock option vested exercisable term                 5 years                  
Stock options are exercisable price per share                 $ 1.68                  
Number of fully vested option issued           16,667     16,667                  
Fair value of stock options                 $ 104,920                  
Stock price per share                 $ 1.5738                  
Stock options fully vested amount, fair value                 $ 101,475                  
Dr. Winson Sze Chun Ho [Member]                                    
Stock options granted to purchase common stock, issued               8,333                    
Dr. Stephen Forman [Member]                                    
Stock options granted to purchase common stock, issued               8,333                    
Dr. Philip Palmedo [Member]                                    
Stock options granted to purchase common stock, issued               8,333                    
Eric Forman [Member]                                    
Stock option vested exercisable term               5 years                    
Stock options are exercisable price per share               $ 6.60                    
Number of fully vested option issued               16,667                    
Stock price per share               $ 5.6718                    
Stock options fully vested amount, fair value               $ 94,525                    
Eric Forman [Member] | Employment Agreement [Member]                                    
Stock options granted to purchase common stock, issued     58,333                              
Stock option vested exercisable term     5 years                              
Stock options are exercisable price per share     $ 7.14                              
Fair value of stock options     $ 400,855                              
Stock price per share     $ 6.8718                              
Stock options fully vested amount, fair value $ 100,214                                  
Stock options description     On July 15, 2020, as amended on August 12, 2020, in connection with the employment agreement entered into with Eric Forman, Mr. Forman was granted options for 58,333 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing price of the Company's common stock on the grant date. The options vested as to 25% on August 12, 2020, and will vest 25% on each of the first, second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 12, 2020 through August 12, 2023. During the year ended December 31, 2020, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $138,926 with respect to these stock options.                              
Eric Forman [Member] | General and Administrative Expense [Member]                                    
Stock based compensation                         $ 138,926          
Mr. Johnson's [Member]                                    
Stock options granted to purchase common stock, issued             83,333                      
Stock option vested exercisable term             5 years                      
Stock options are exercisable price per share             $ 6.00                      
Stock price per share             $ 5.2083                      
Stock options fully vested amount, fair value             $ 434,024                      
Dr. James Miser [Member] | Employment Agreement [Member]                                    
Stock options granted to purchase common stock, issued   83,334                                
Stock option vested exercisable term   5 years                                
Stock options are exercisable price per share   $ 7.14                                
Fair value of stock options   $ 572,650                                
Stock price per share   $ 6.8718                                
Stock options fully vested amount, fair value   $ 143,163                                
Stock options description   Dr. Miser was granted options for 83,334 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing price of the Company's common stock on the effective date of the employment agreement. The options vested as to 25% on the effective date, and will vest 25% on each of the first, second and third anniversaries of the effective date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $572,650 ($6.8718 per share), of which $143,163 was attributable to the stock options fully-vested on August 1, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 1, 2020 through August 1, 2023. During the year ended December 31, 2020, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $202,782 with respect to these stock options.                                
Dr. James Miser [Member] | General and Administrative Expense [Member]                                    
Stock based compensation                       $ 202,782            
Robert N. Weingarten [Member] | Employment Agreement [Member]                                    
Stock options granted to purchase common stock, issued 58,333                                  
Stock option vested exercisable term 5 years                                  
Stock options are exercisable price per share $ 7.14                                  
Fair value of stock options $ 400,855                                  
Stock price per share $ 6.8718                                  
Stock options fully vested amount, fair value $ 100,214                                  
Stock options description On August 12, 2020, in connection with the employment agreement entered into with Robert N. Weingarten, Mr. Weingarten was granted options for 58,333 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing price of the Company's common stock on the grant date. The options vested as to 25% on August 12, 2020, and will vest 25% on each of the first, second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 12, 2020 through August 12, 2023. During the year ended December 31, 2020, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $138,926 with respect to these stock options.                                  
Robert N. Weingarten [Member] | General and Administrative Expense [Member]                                    
Stock based compensation                         $ 138,926          
2007 Stock Compensation Plan [Member]                                    
Stock options granted to purchase common stock, issued                         208,333          
Stock options granted to purchase common stock, outstanding                       208,333 208,333          
2007 Stock Compensation Plan [Member] | Maximum [Member]                                    
Number of restricted stock issued                     416,667              
2020 Stock Incentive Plan [Member] | Maximum [Member]                                    
Number of restricted stock issued       2,333,333